MetLife Investment Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.2M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $22M | Buy |
|
|||||
|
2024
Q4 | $2.34M | Buy |
|
|||||
|
2024
Q3 | $2.6M | Hold |
|
|||||
|
2024
Q2 | $1.46M | Buy |
|
|||||
|
2024
Q1 | $716K | Sell |
|
|||||
|
2023
Q4 | $499K | Hold |
|
|||||
|
2023
Q3 | $395K | Hold |
|
|||||
|
2023
Q2 | $408K | Hold |
|
|||||
|
2023
Q1 | $366K | Buy |
|
|||||
|
2022
Q4 | $339K | Sell |
|
|||||
|
2022
Q3 | $239K | Hold |
|
|||||
|
2022
Q2 | $195K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $106K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $117K | Buy |
|